ATE198353T1 - Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung - Google Patents

Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung

Info

Publication number
ATE198353T1
ATE198353T1 AT89113852T AT89113852T ATE198353T1 AT E198353 T1 ATE198353 T1 AT E198353T1 AT 89113852 T AT89113852 T AT 89113852T AT 89113852 T AT89113852 T AT 89113852T AT E198353 T1 ATE198353 T1 AT E198353T1
Authority
AT
Austria
Prior art keywords
somatotropines
stabilization
site
modification
specific mutagenesis
Prior art date
Application number
AT89113852T
Other languages
English (en)
Inventor
Susan Mancini Cady
John Steele Logan
Brian Lee Buckwalter
Gerald W Stockton
Deborah Tardy Chaleff
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE198353T1 publication Critical patent/ATE198353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89113852T 1988-08-24 1989-07-27 Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung ATE198353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23606088A 1988-08-24 1988-08-24
US37269989A 1989-07-03 1989-07-03

Publications (1)

Publication Number Publication Date
ATE198353T1 true ATE198353T1 (de) 2001-01-15

Family

ID=26929421

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89113852T ATE198353T1 (de) 1988-08-24 1989-07-27 Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung

Country Status (18)

Country Link
US (1) US5891840A (de)
EP (1) EP0355460B1 (de)
JP (1) JP2894355B2 (de)
AR (1) AR245138A1 (de)
AT (1) ATE198353T1 (de)
AU (1) AU630105B2 (de)
DE (1) DE68929273T2 (de)
DK (1) DK416589A (de)
ES (1) ES2154627T3 (de)
FI (1) FI104908B (de)
GR (1) GR3035608T3 (de)
HU (1) HU217095B (de)
IE (1) IE892706A1 (de)
IL (1) IL91156A (de)
NO (1) NO893387L (de)
NZ (1) NZ230342A (de)
PT (1) PT91512B (de)
YU (1) YU163289A (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006186A2 (en) * 1987-02-19 1988-08-25 The Upjohn Company cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5951972A (en) * 1990-05-04 1999-09-14 American Cyanamid Company Stabilization of somatotropins and other proteins by modification of cysteine residues
ATE163431T1 (de) * 1990-05-04 1998-03-15 American Cyanamid Co Stabilisierung von somatotropin durch modifizierung von cysteinsresten
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals
US6894023B1 (en) 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
NZ240718A (en) * 1990-11-30 1996-10-28 Bio Technology General Corp Somatotropin analogues carrying mutations in the alpha-helix-1 region
US5310882A (en) * 1990-11-30 1994-05-10 American Cyanamid Company Somatotropins with alterations in the α-helix 3 region
GB9100381D0 (en) * 1991-01-09 1991-02-20 Erba Carlo Spa Human bfgf derivatives,their analogs and process for their production
FR2671554A1 (fr) * 1991-01-11 1992-07-17 Clonatec Sa Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.
AU654563B2 (en) * 1991-07-24 1994-11-10 Imperial Chemical Industries Plc Proteins
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
CA2296770A1 (en) 1997-07-14 1999-01-28 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins
US7270809B2 (en) 1997-07-14 2007-09-18 Bolder Biotechnology, Inc. Cysteine variants of alpha interferon-2
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
JP4873818B2 (ja) 2000-05-16 2012-02-08 ボルダー バイオテクノロジー， インコーポレイテッド 遊離システイン残基を含有するタンパク質をリフォールディングする方法
US6878861B2 (en) 2000-07-21 2005-04-12 Washington State University Research Foundation Acyl coenzyme A thioesterases
US7060442B2 (en) 2000-10-30 2006-06-13 Regents Of The University Of Michigan Modulators on Nod2 signaling
AU2003263552A1 (en) * 2002-09-09 2004-03-29 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2007041614A2 (en) 2005-10-03 2007-04-12 Bolder Biotechnology, Inc. Long acting vegf inhibitors and methods of use
DK1931379T3 (da) 2005-10-07 2013-08-19 Sec Dep For Health Proteiner med forbedret opløselighed samt fremgangsmåder til frembringelse og anvendelse af samme
EP2102355B1 (de) 2006-12-14 2016-03-02 Bolder Biotechnology, Inc. Proteine und peptide mit langer wirkung sowie verfahren zu ihrer herstellung und verwendung
CA2733200A1 (en) * 2008-08-06 2010-02-11 Novo Nordisk Health Care Ag Conjugated proteins with prolonged in vivo efficacy
MX2011007736A (es) * 2009-01-22 2011-09-06 Novo Nordisk Healthcare Ag Compuestos de hormona del crecimiento estables.
CN102612376A (zh) 2009-08-06 2012-07-25 诺沃-诺迪斯克保健股份有限公司 具有延长的体内功效的生长激素
CN107674121A (zh) * 2009-12-21 2018-02-09 Ambrx 公司 经过修饰的牛促生长素多肽和其用途
JP5875527B2 (ja) 2010-01-22 2016-03-02 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー ｉｎ−ｖｉｖｏにおける効力が延長された成長ホルモン
CA2787895A1 (en) 2010-01-22 2011-07-28 Novo Nordisk Health Care Ag Stable growth hormone compounds
ES2737024T3 (es) * 2012-08-31 2020-01-09 Glaxosmithkline Biologicals Sa Proteínas estabilizadas para inmunización contra Staphylococcus aureus
US11045523B2 (en) 2013-04-05 2021-06-29 Novo Nordisk Healthcare Ag Formulation of growth hormone albumin-binder conjugate
KR20180003677A (ko) * 2016-06-30 2018-01-10 주식회사 크레아플래닛 인간 성장호르몬 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US5079230A (en) * 1988-09-12 1992-01-07 Pitman-Moore, Inc. Stable bioactive somatotropins
KR910700264A (ko) * 1989-01-19 1991-03-14 로버트 에이. 아미테이지 소마토트로핀 유사물
AU620673B2 (en) * 1989-01-31 1992-02-20 Pharmacia & Upjohn Company Somatotropin analogs
US5849694A (en) * 1990-07-16 1998-12-15 Synenki; Richard M. Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
AU4020289A (en) 1990-03-15
ES2154627T3 (es) 2001-04-16
DE68929273T2 (de) 2001-07-05
IL91156A0 (en) 1990-03-19
DK416589D0 (da) 1989-08-23
EP0355460A3 (de) 1991-04-03
JPH034797A (ja) 1991-01-10
IL91156A (en) 1995-05-26
NZ230342A (en) 1992-08-26
EP0355460A2 (de) 1990-02-28
FI893963A0 (fi) 1989-08-23
PT91512B (pt) 1995-05-31
GR3035608T3 (en) 2001-06-29
HU217095B (hu) 1999-11-29
DK416589A (da) 1990-02-25
JP2894355B2 (ja) 1999-05-24
IE892706A1 (en) 1991-01-16
NO893387L (no) 1990-02-26
NO893387D0 (no) 1989-08-23
US5891840A (en) 1999-04-06
YU163289A (en) 1992-05-28
PT91512A (pt) 1990-03-08
FI104908B (fi) 2000-04-28
HUT51331A (en) 1990-04-28
IE892706L (en) 1990-02-24
EP0355460B1 (de) 2000-12-27
FI893963A (fi) 1990-02-25
AU630105B2 (en) 1992-10-22
DE68929273D1 (de) 2001-02-01
AR245138A1 (es) 1993-12-30

Similar Documents

Publication Publication Date Title
ATE198353T1 (de) Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung
DE69024868D1 (de) Verbessertes Chloren von Sucrose-6-Ester
NO820350L (no) Fortykningsmiddel og vandig blanding inneholdende dette
NO171881C (no) Klorsyregenerende blanding
DE68918995D1 (de) Montage von elektronischen Bauteilen.
KR890700191A (ko) 전자 제어장치
DE69008640T2 (de) Zersetzung von Schadstoffen.
DE58903039D1 (de) Quaderfoermiges gehaeuse zum einbau von bauelementen.
DK163842C (da) Programmerbart elektrisk ur
KR870017509U (ko) 화면 안정화회로
BR8605044A (pt) Composicoes explosivas contendo emulsao
GR3001564T3 (en) Substituted alkynic thiocyanates, biocidal compositions containing them and uses of such compositions
GB8828594D0 (en) Recovery of silver from photographic materials
KR880011722U (ko) 세정식 염소가스 중화장치
KR870002694U (ko) 전자시계용 무브먼트 하우징
KR880007644U (ko) 염소 가스 중화 장치
KR870014878U (ko) 염소가스투입기의 역수방지기
KR850007811U (ko) 전자식 타이머를 사용한 가스배출기
KR880003802U (ko) 전자제품 보호용 패드를 이용한 리모콘 수용구조
KR870018109U (ko) 염소가스 중화장치
TH5837EX (th) การเติมคลอรีนกับสารผสมที่มีโลหะประกอบอยู่ด้วย
KR870014153U (ko) 오존 발생 회로
KR890018389U (ko) 유선 티브이(tv)의 보안회로
BR8403490A (pt) Hidrometro eletronico
BR6401135U (pt) Hidrometro eletronico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee